211 related articles for article (PubMed ID: 16604677)
21. Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapy.
Knutsen S; Hafslund R; Monge OR; Valen H; Muren LP; Rekstad BL; Krohn J; Dahl O
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1159-66. PubMed ID: 11704341
[TBL] [Abstract][Full Text] [Related]
22. A Systematic Comparison of Dose Distributions Delivered in
Trofimov AV; Aronow ME; Gragoudas ES; Keane FK; Kim IK; Shih HA; Bhagwat MS
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):501-510. PubMed ID: 35878716
[TBL] [Abstract][Full Text] [Related]
23. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
24. Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma.
Hérault J; Iborra N; Serrano B; Chauvel P
Med Phys; 2005 Apr; 32(4):910-9. PubMed ID: 15895573
[TBL] [Abstract][Full Text] [Related]
25. Quantification of dose perturbations induced by external and internal accessories in ocular proton therapy and evaluation of their dosimetric impact.
Carnicer A; Angellier G; Thariat J; Sauerwein W; Caujolle JP; Hérault J
Med Phys; 2013 Jun; 40(6):061708. PubMed ID: 23718587
[TBL] [Abstract][Full Text] [Related]
26. Monte Carlo dosimetry modeling of focused kV x-ray radiotherapy of eye diseases with potential nanoparticle dose enhancement.
Yan H; Ma X; Sun W; Mendez S; Stryker S; Starr-Baier S; Delliturri G; Zhu D; Nath R; Chen Z; Roberts K; MacDonald CA; Liu W
Med Phys; 2018 Oct; 45(10):4720-4733. PubMed ID: 30133705
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: a Monte Carlo study.
Bues M; Newhauser WD; Titt U; Smith AR
Radiat Prot Dosimetry; 2005; 115(1-4):164-9. PubMed ID: 16381706
[TBL] [Abstract][Full Text] [Related]
28. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
[TBL] [Abstract][Full Text] [Related]
29. A simple calibration method for 106Ru-106Rh eye applicators.
Kovacević N; Vrtar M; Vekić B
Radiother Oncol; 2005 Mar; 74(3):293-9. PubMed ID: 15763310
[TBL] [Abstract][Full Text] [Related]
30. Quantifying the dosimetric influences of radiation coverage and brachytherapy implant placement uncertainty on eye plaque size selection.
Gagne NL; Rivard MJ
Brachytherapy; 2013; 12(5):508-20. PubMed ID: 23466357
[TBL] [Abstract][Full Text] [Related]
31. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
[TBL] [Abstract][Full Text] [Related]
32. COMS eye plaque brachytherapy dosimetry simulations for 103Pd, 125I, and 131Cs.
Melhus CS; Rivard MJ
Med Phys; 2008 Jul; 35(7):3364-71. PubMed ID: 18697560
[TBL] [Abstract][Full Text] [Related]
33. Phantom size in brachytherapy source dosimetric studies.
Pérez-Calatayud J; Granero D; Ballester F
Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
[TBL] [Abstract][Full Text] [Related]
34. Comparison of 16 mm OSU-Nag and COMS eye plaques.
Zhang H; Davidorf F; Qi Y
J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
[TBL] [Abstract][Full Text] [Related]
35. Accurate estimation of dose distributions inside an eye irradiated with 106Ru plaques.
Brualla L; Sempau J; Zaragoza FJ; Wittig A; Sauerwein W
Strahlenther Onkol; 2013 Jan; 189(1):68-73. PubMed ID: 23161122
[TBL] [Abstract][Full Text] [Related]
36. Independent dosimetric assessment of the model EP917 episcleral brachytherapy plaque.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Sep; 41(9):092102. PubMed ID: 25186402
[TBL] [Abstract][Full Text] [Related]
37. BEDVH-A method for evaluating biologically effective dose volume histograms: application to eye plaque brachytherapy implants.
Gagne NL; Leonard KL; Huber KE; Mignano JE; Duker JS; Laver NV; Rivard MJ
Med Phys; 2012 Feb; 39(2):976-83. PubMed ID: 22320806
[TBL] [Abstract][Full Text] [Related]
38. ROPES eye plaque brachytherapy dosimetry for two models of (103)Pd seeds.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Australas Phys Eng Sci Med; 2011 Jun; 34(2):223-31. PubMed ID: 21452056
[TBL] [Abstract][Full Text] [Related]
39. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
40. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
